CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine
To reduce the biothreat posed by anthrax, efforts are under way to improve the protection
afforded by vaccination. This work examines the ability of immunostimulatory CpG …
afforded by vaccination. This work examines the ability of immunostimulatory CpG …
Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D, L-lactide-co-glycolide) microspheres
K Allaoui-Attarki, E Fattal, S Pecquet, S Trollé… - Vaccine, 1998 - Elsevier
Poly (d, l-lactide-co-glycolide) microspheres loaded with phosphorylcholine linked to
thyroglobulin (PC-Thyr) as protein carrier were prepared. The entrapment efficiency reached …
thyroglobulin (PC-Thyr) as protein carrier were prepared. The entrapment efficiency reached …
Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems
J Singh, S Pandit, VW Bramwell, HO Alpar - Methods, 2006 - Elsevier
Poly-(ε-caprolactone)(PCL), a poly (lactide-co-glycolide)(PLGA)-PCL blend and co-polymer
nanoparticles encapsulating diphtheria toxoid (DT) were investigated for their potential as a …
nanoparticles encapsulating diphtheria toxoid (DT) were investigated for their potential as a …
Allergen‐loaded biodegradable poly(d,l‐lactic‐co‐glycolic) acid nanoparticles down‐regulate an ongoing Th2 response in the BALB/c mouse model
I Schöll, A Weissenböck… - Clinical & …, 2004 - Wiley Online Library
Background and objective Biocompatible and biodegradable microparticles have gained
interest as antigen delivery systems during the recent years. We investigated whether …
interest as antigen delivery systems during the recent years. We investigated whether …
Modulation of the specific allergic response by mite allergens encapsulated into liposomes
L Calderón, E Facenda, L Machado, K Uyema… - Vaccine, 2006 - Elsevier
Liposomes are non toxic and biodegradable lipid vesicles, which are safe and effective
adjuvants to induce Th1-skewed immune response. Therefore, the encapsulation of …
adjuvants to induce Th1-skewed immune response. Therefore, the encapsulation of …
Microparticles for intranasal immunization
M Vajdy, DT O'Hagan - Advanced drug delivery reviews, 2001 - Elsevier
Of the several routes available for mucosal immunization, the nasal route is particularly
attractive because of ease of administration and the induction of potent immune responses …
attractive because of ease of administration and the induction of potent immune responses …
Peptide/protein vaccine delivery system based on PLGA particles
M Allahyari, E Mohit - Human vaccines & immunotherapeutics, 2016 - Taylor & Francis
abstract Due to the excellent safety profile of poly (D, L-lactide-co-glycolide)(PLGA) particles
in human, and their biodegradability, many studies have focused on the application of PLGA …
in human, and their biodegradability, many studies have focused on the application of PLGA …
Comparison of the effects of various fine particles on IgE antibody production in mice inhaling Japanese cedar pollen allergens
K Maejima, K Tamura, Y Taniguchi… - Journal of toxicology …, 1997 - Taylor & Francis
The adjuvant effects of various fine particles [Kanto loam dust, fly ash, carbon black, diesel
exhaust particles (DEP), and aluminum hydroxide (alum)] on immunoglobulin E (IgE) …
exhaust particles (DEP), and aluminum hydroxide (alum)] on immunoglobulin E (IgE) …
Alginate microparticles loaded with lipopolysaccharide subunit antigen for mucosal vaccination against Klebsiella pneumoniae
Klebsiella pneumoniae (K. pneumoniae) is one of the commonest causes of nosocomial
infections in human beings. Since K. pneumoniae infections are air borne type, controlling it …
infections in human beings. Since K. pneumoniae infections are air borne type, controlling it …
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally
KS Jaganathan, SP Vyas - Vaccine, 2006 - Elsevier
Surface-modified dl-lactide/glycolide copolymer (PLGA) microspheres with chitosan (CS)
were developed for nasal immunization using recombinant Hepatitis B (HBsAg) surface …
were developed for nasal immunization using recombinant Hepatitis B (HBsAg) surface …